pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-642b |
Genomic Coordinates | chr19: 45674932 - 45675008 |
Description | Homo sapiens miR-642b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-642b-3p | |||||||||||||||||||||||||||
Sequence | 47| AGACACAUUUGGAGAGGGACCC |68 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TXNIP | ||||||||||||||||||||
Synonyms | ARRDC6, EST01027, HHCPA78, THIF, VDUP1 | ||||||||||||||||||||
Description | thioredoxin interacting protein | ||||||||||||||||||||
Transcript | NM_006472 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TXNIP | |||||||||||||||||||||
3'UTR of TXNIP (miRNA target sites are highlighted) |
>TXNIP|NM_006472|3'UTR 1 GCATGTGGAAGAAAAGAAGCAGCTTTACCTACTTGTTTCTTTTTGTCTCTCTTCCTGGACACTCACTTTTTCAGAGACTC 81 AACAGTCTCTGCAATGGAGTGTGGGTCCACCTTAGCCTCTGACTTCCTAATGTAGGAGGTGGTCAGCAGGCAATCTCCTG 161 GGCCTTAAAGGATGCGGACTCATCCTCAGCCAGCGCCCATGTTGTGATACAGGGGTGTTTGTTGGATGGGTTTAAAAATA 241 ACTAGAAAAACTCAGGCCCATCCATTTTCTCAGATCTCCTTGAAAATTGAGGCCTTTTCGATAGTTTCGGGTCAGGTAAA 321 AATGGCCTCCTGGCGTAAGCTTTTCAAGGTTTTTTGGAGGCTTTTTGTAAATTGTGATAGGAACTTTGGACCTTGAACTT 401 ACGTATCATGTGGAGAAGAGCCAATTTAACAAACTAGGAAGATGAAAAGGGAAATTGTGGCCAAAACTTTGGGAAAAGGA 481 GGTTCTTAAAATCAGTGTTTCCCCTTTGTGCACTTGTAGAAAAAAAAGAAAAACCTTCTAGAGCTGATTTGATGGACAAT 561 GGAGAGAGCTTTCCCTGTGATTATAAAAAAGGAAGCTAGCTGCTCTACGGTCATCTTTGCTTAGAGTATACTTTAACCTG 641 GCTTTTAAAGCAGTAGTAACTGCCCCACCAAAGGTCTTAAAAGCCATTTTTGGAGCCTATTGCACTGTGTTCTCCTACTG 721 CAAATATTTTCATATGGGAGGATGGTTTTCTCTTCATGTAAGTCCTTGGAATTGATTCTAAGGTGATGTTCTTAGCACTT 801 TAATTCCTGTCAAATTTTTTGTTCTCCCCTTCTGCCATCTTAAATGTAAGCTGAAACTGGTCTACTGTGTCTCTAGGGTT 881 AAGCCAAAAGACAAAAAAAATTTTACTACTTTTGAGATTGCCCCAATGTACAGAATTATATAATTCTAACGCTTAAATCA 961 TGTGAAAGGGTTGCTGCTGTCAGCCTTGCCCACTGTGACTTCAAACCCAAGGAGGAACTCTTGATCAAGATGCCCAACCC 1041 TGTGATCAGAACCTCCAAATACTGCCATGAGAAACTAGAGGGCAGGTCTTCATAAAAGCCCTTTGAACCCCCTTCCTGCC 1121 CTGTGTTAGGAGATAGGGATATTGGCCCCTCACTGCAGCTGCCAGCACTTGGTCAGTCACTCTCAGCCATAGCACTTTGT 1201 TCACTGTCCTGTGTCAGAGCACTGAGCTCCACCCTTTTCTGAGAGTTATTACAGCCAGAAAGTGTGGGCTGAAGATGGTT 1281 GGTTTCATGTTTTTGTATTATGTATCTTTTTGTATGGTAAAGACTATATTTTGTACTTAACCAGATATATTTTTACCCCA 1361 GATGGGGATATTCTTTGTAAAAAATGAAAATAAAGTTTTTTTAATGGAAAAAAAAATGTCTGTGAAAAAAAAAAAAAAAA 1441 AA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000369317.4 | 3UTR | CCCCUCACUGCAGCUGCCAGCACUUGGUCAGUCACUCUCAGCCAUAGCACUUUGUUCACUGUCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
77 hsa-miR-642b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT082888 | ZNF543 | zinc finger protein 543 | 2 | 2 | ||||||||
MIRT108294 | BHLHB9 | basic helix-loop-helix family member b9 | 2 | 2 | ||||||||
MIRT348737 | ZNF350 | zinc finger protein 350 | 2 | 2 | ||||||||
MIRT381384 | EXOG | exo/endonuclease G | 2 | 2 | ||||||||
MIRT452245 | TRAM1 | translocation associated membrane protein 1 | 2 | 2 | ||||||||
MIRT459262 | ADRBK1 | G protein-coupled receptor kinase 2 | 2 | 2 | ||||||||
MIRT468117 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT468402 | SETD3 | SET domain containing 3 | 2 | 2 | ||||||||
MIRT469079 | RNF168 | ring finger protein 168 | 2 | 2 | ||||||||
MIRT471690 | OXR1 | oxidation resistance 1 | 2 | 2 | ||||||||
MIRT477353 | EOGT | EGF domain specific O-linked N-acetylglucosamine transferase | 2 | 4 | ||||||||
MIRT479600 | CDC25B | cell division cycle 25B | 2 | 2 | ||||||||
MIRT482377 | AFF4 | AF4/FMR2 family member 4 | 2 | 4 | ||||||||
MIRT484029 | LARP4B | La ribonucleoprotein domain family member 4B | 2 | 2 | ||||||||
MIRT490988 | USP22 | ubiquitin specific peptidase 22 | 2 | 2 | ||||||||
MIRT493250 | MEF2D | myocyte enhancer factor 2D | 2 | 2 | ||||||||
MIRT493850 | FOXN3 | forkhead box N3 | 2 | 4 | ||||||||
MIRT496086 | C17orf85 | nuclear cap binding subunit 3 | 2 | 2 | ||||||||
MIRT500630 | TXNIP | thioredoxin interacting protein | 2 | 2 | ||||||||
MIRT501048 | SMEK1 | protein phosphatase 4 regulatory subunit 3A | 2 | 2 | ||||||||
MIRT525186 | ZNF257 | zinc finger protein 257 | 2 | 4 | ||||||||
MIRT534875 | QSER1 | glutamine and serine rich 1 | 2 | 2 | ||||||||
MIRT539336 | AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | 2 | 2 | ||||||||
MIRT553814 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 2 | 2 | ||||||||
MIRT555959 | NRAS | NRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT556289 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT561212 | ZSWIM1 | zinc finger SWIM-type containing 1 | 2 | 2 | ||||||||
MIRT567328 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT572385 | LRRC6 | leucine rich repeat containing 6 | 2 | 2 | ||||||||
MIRT575529 | Map4 | microtubule-associated protein 4 | 2 | 2 | ||||||||
MIRT575684 | Map1b | microtubule-associated protein 1B | 2 | 2 | ||||||||
MIRT576828 | Tgfbr3 | transforming growth factor, beta receptor III | 2 | 2 | ||||||||
MIRT576953 | Pigs | phosphatidylinositol glycan anchor biosynthesis, class S | 2 | 3 | ||||||||
MIRT608316 | SYK | spleen associated tyrosine kinase | 2 | 4 | ||||||||
MIRT609794 | PINX1 | PIN2/TERF1 interacting telomerase inhibitor 1 | 2 | 2 | ||||||||
MIRT609991 | PIGS | phosphatidylinositol glycan anchor biosynthesis class S | 2 | 3 | ||||||||
MIRT611381 | PNMAL1 | paraneoplastic Ma antigen family member 8A | 2 | 4 | ||||||||
MIRT613566 | YY2 | YY2 transcription factor | 2 | 2 | ||||||||
MIRT614612 | MVK | mevalonate kinase | 2 | 2 | ||||||||
MIRT615497 | MPP2 | membrane palmitoylated protein 2 | 2 | 2 | ||||||||
MIRT616941 | OTUD7A | OTU deubiquitinase 7A | 2 | 2 | ||||||||
MIRT617576 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | 2 | 2 | ||||||||
MIRT618214 | SPTLC3 | serine palmitoyltransferase long chain base subunit 3 | 2 | 4 | ||||||||
MIRT619885 | ABHD17B | abhydrolase domain containing 17B | 2 | 2 | ||||||||
MIRT620401 | MYO1H | myosin IH | 2 | 2 | ||||||||
MIRT620517 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT622166 | SMYD1 | SET and MYND domain containing 1 | 2 | 2 | ||||||||
MIRT623195 | MTX3 | metaxin 3 | 2 | 2 | ||||||||
MIRT623440 | KIAA0408 | KIAA0408 | 2 | 4 | ||||||||
MIRT624837 | ACAP2 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | 2 | 2 | ||||||||
MIRT625706 | SHROOM1 | shroom family member 1 | 2 | 2 | ||||||||
MIRT628159 | HIP1 | huntingtin interacting protein 1 | 2 | 2 | ||||||||
MIRT629496 | SGIP1 | SH3 domain GRB2 like endophilin interacting protein 1 | 2 | 2 | ||||||||
MIRT630240 | SOGA3 | SOGA family member 3 | 2 | 4 | ||||||||
MIRT630521 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 4 | ||||||||
MIRT635676 | COX18 | COX18, cytochrome c oxidase assembly factor | 2 | 4 | ||||||||
MIRT637820 | CACNA1B | calcium voltage-gated channel subunit alpha1 B | 2 | 2 | ||||||||
MIRT637943 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 2 | ||||||||
MIRT640490 | EXOC5 | exocyst complex component 5 | 2 | 2 | ||||||||
MIRT642722 | ATXN3 | ataxin 3 | 2 | 2 | ||||||||
MIRT649153 | LRTM1 | leucine rich repeats and transmembrane domains 1 | 2 | 2 | ||||||||
MIRT649610 | ITPKC | inositol-trisphosphate 3-kinase C | 2 | 2 | ||||||||
MIRT661016 | ABCA12 | ATP binding cassette subfamily A member 12 | 2 | 2 | ||||||||
MIRT661055 | RPL18A | ribosomal protein L18a | 2 | 2 | ||||||||
MIRT684041 | FOLR1 | folate receptor 1 | 2 | 2 | ||||||||
MIRT691014 | CRTC3 | CREB regulated transcription coactivator 3 | 2 | 2 | ||||||||
MIRT698908 | SPPL2A | signal peptide peptidase like 2A | 2 | 2 | ||||||||
MIRT700981 | PDE4D | phosphodiesterase 4D | 2 | 2 | ||||||||
MIRT701722 | MTMR12 | myotubularin related protein 12 | 2 | 2 | ||||||||
MIRT702724 | INSIG1 | insulin induced gene 1 | 2 | 2 | ||||||||
MIRT705057 | C5orf15 | chromosome 5 open reading frame 15 | 2 | 2 | ||||||||
MIRT705216 | BRWD1 | bromodomain and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT706088 | HNRNPU | heterogeneous nuclear ribonucleoprotein U | 2 | 2 | ||||||||
MIRT709458 | KRTAP19-1 | keratin associated protein 19-1 | 2 | 2 | ||||||||
MIRT711396 | RANBP2 | RAN binding protein 2 | 2 | 2 | ||||||||
MIRT720573 | SDHAF2 | succinate dehydrogenase complex assembly factor 2 | 2 | 2 | ||||||||
MIRT725366 | MTF2 | metal response element binding transcription factor 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|